Connection
Priya Rolfes to Janus Kinase Inhibitors
This is a "connection" page, showing publications Priya Rolfes has written about Janus Kinase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.149 |
|
|
|
-
Dolinger MT, Rolfes P, Phan BL, Dubinsky MC. Letter: tofacitinib use for biologic-refractory paediatric inflammatory bowel disease. Aliment Pharmacol Ther. 2019 10; 50(8):966-967.
Score: 0.149